Transapical beating-heart septal myectomy for hypertrophic cardiomyopathy with latent obstruction
European Journal of Cardio-Thoracic Surgery · 02.01.2024 · 65 (1)
DOI: 10.1093/ejcts/ezad425 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, online erschienen am 19.12.2023. Verfasst von Jiangtao Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Mitral Valve Insufficiency, Cardiac Surgical Procedures, Ventricular Outflow Obstruction, Cardiomyopathy, Hypertrophic. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
OBJECTIVES A novel transapical beating-heart septal myectomy (TA-BSM) procedure was performed for patients with latent obstruction through the left intercostal incision and without cardiopulmonary bypass. This study aims to demonstrate the experience of the TA-BSM procedure for patients with latent obstruction and compare outcomes to patients with resting obstruction. METHODS We studied 120 symptomatic hypertrophic obstructive cardiomyopathy patients (33 with latent obstruction and 87 with resting obstruction) who underwent TA-BSM. Demographic profiles, echocardiogram-derived ventricular morphology and haemodynamics and clinical outcomes were analysed. RESULTS There were no important differences in baseline clinical characteristics between patients with latent obstruction and resting obstruction, including age, symptoms, comorbidities and medical history. Patients with latent obstruction had lower basal septum thickness, higher midventricular wall thickness, smaller left atrial chamber size and more frequency of mitral subvalvular anomalies. There was no difference in early (<30 days) deaths (0/33 vs 1/87, P > 0.999) and mid-term survival between patients with latent obstruction and resting obstruction. At 6 months after surgery, 31 (93.9%) patients with latent obstruction and 80 (92.0%) with resting obstruction achieved optimal procedural success, which was defined as a maximal gradient (after provocation) <30 mmHg and mitral regurgitation ≤ grade 1+ without mortality. Maximal left ventricular outflow tract gradient, basal septum thickness, midventricular wall thickness, mitral regurgitation grade and left atrial chamber size were significantly decreased after TA-BSM. In the follow-up, the New York Heart Association class was significantly improved following surgery. CONCLUSIONS TA-BSM preserved favourable gold-standard guideline desired outcomes through real-time echocardiographic-guided resection. Equipoise of outcomes for this procedure regardless of degree of resting left ventricular outflow tract gradients supports operative management with this approach in symptomatic patients with latent obstruction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiovascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Key Laboratory of Organ Transplantation, Ministry of Education, Wuhan, China.
- NHC Key Laboratory of Organ Transplantation, Ministry of Health, Wuhan, China.
ORCID-Profile: Xiang Wei
Zitieren
APA
Li, J., & Wei, X. (2024). Transapical beating-heart septal myectomy for hypertrophic cardiomyopathy with latent obstruction. European Journal of Cardio-Thoracic Surgery, 65(1). https://doi.org/10.1093/ejcts/ezad425
Vancouver
Li J, Wei X. Transapical beating-heart septal myectomy for hypertrophic cardiomyopathy with latent obstruction. European Journal of Cardio-Thoracic Surgery. 2024;65(1). doi:10.1093/ejcts/ezad425
BibTeX
@article{Li2024,
author = {Li, Jiangtao and Wei, Xiang},
title = {Transapical beating-heart septal myectomy for hypertrophic cardiomyopathy with latent obstruction},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2024},
volume = {65},
number = {1},
doi = {10.1093/ejcts/ezad425}
}
EUVIMED